Atrium Therapeutics, Inc.
NASDAQ: RNA
$12.84
as on
Atrium Therapeutics, Inc. Stock Performance
as on August 19, 2026 at 2:16 pm IST
Day's Low
Day's High
$12.72$12.96
0.93%
Downside
0.93%
Upside
52 Week's Low
52 Week's High
$11.13$73.0613.32%
Downside
469.00%
Upside
Atrium Therapeutics, Inc. share price movements today
- Previous Close
- $12.96
- Open
- $12.91
- Volume
- 287.3K
- Market Cap
- $219.6M
- Day's Low - High
- $12.72 - $12.96
- 52 Week Low - High
- $11.13 - $73.06
Atrium Therapeutics, Inc. Historical Returns
- 1 Month Return
- + 5.68 %
- 3 Month Return
- -2.95 %
- 1 Year Return
- -72.37 %
- 3 Year Return
- + 55.64 %
- 5 Year Return
- -31.45 %
Atrium Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Atrium Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$219.6M
EPS (TTM)
-5.15
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.62
Industry PE ratio
-1.5966015625
PEG Ratio
-0.04617977528089888
EBITDA
-408.1M
Revenue (TTM)
36.8M
Profit Margin
99.26%
Return On Equity TTM
-29.67%
Atrium Therapeutics, Inc. Stock Valuation
Track how Atrium Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Atrium Therapeutics, Inc. in the last 5 years
Lowest (-10.07x)
December 31, 2024
Today (-3.29x)
December 31, 2025
Industry (-1.60x)
December 31, 2025
Highest (-3.11x)
December 31, 2023
Today’s Price to Earnings Ratio: -3.29x
Atrium Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Atrium Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $219.6M | -31.45% | -4.62 | 99.26% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Atrium Therapeutics, Inc. Stock including INR - Dollar returns
The Atrium Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Atrium Therapeutics, Inc. investment value today
Current value as on today
₹30,276
Returns
Returns from Atrium Therapeutics, Inc. Stock
Dollar Impact
₹2,645 (+2.65%)
Analyst Recommendation on Atrium Therapeutics, Inc. Stock
Based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Atrium Therapeutics, Inc.. Average target price of $25
Atrium Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Atrium Therapeutics, Inc..
What analysts predicted
48.64%UPSIDE
Target Price
$25
Current Price
$12.84
Analyzed by
4 Analysts
Target
$25.00
Atrium Therapeutics, Inc. target price $25, a slight upside of 48.64% compared to current price of $12.84. According to 4 analysts rating.
Indian Investors' Interest in Atrium Therapeutics, Inc. Stock
Search interest for Atrium Therapeutics, Inc. Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Atrium Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Atrium Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Atrium Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Atrium Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Atrium Therapeutics, Inc. News & Key Events
Insights on Atrium Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, RNA stock has moved up by 5.5%
NO EFFECTAgainst Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 561.9%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 573.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -16.63M → -20.18M (in $), with an average decrease of 21.4% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 19.63M → 3.00M (in $), with an average decrease of 84.7% per quarter
About Atrium Therapeutics, Inc.
| Organisation | Atrium Therapeutics, Inc. |
| Headquarters | 10578 Science Center Drive, San Diego, CA, United States, 92121 |
| Industry | Biotechnology |
| CEO | Ms. Kathleen P. Gallagher |
| E-voting on shares | Click here to vote |
Key Management of Atrium Therapeutics, Inc.
Name | Title |
|---|---|
Ms. Kathleen P. Gallagher | President, CEO & Director |
Mr. Brendan Winslow | Chief Financial Officer |
Dr. Husam Younis Ph.D., Pharm.D. | Chief Scientific Officer |
Ms. Stephanie Kenney | Chief Corporate Affairs Officer |
Dr. Steven George Hughes M.B.A., M.D. | Chief Medical Officer |
Ms. Rocio Martin Hoyos | Chief Strategy Officer |
FAQs
What is Atrium Therapeutics, Inc. share price today?
Atrium Therapeutics, Inc. share price today is $12.84 as on at the close of the market. Atrium Therapeutics, Inc. share today touched a day high of $12.96 and a low of $12.72.
What is the 52 week high and 52 week low for Atrium Therapeutics, Inc. share?
Atrium Therapeutics, Inc. share touched a 52 week high of $73.06 on and a 52 week low of $11.13 on . Atrium Therapeutics, Inc. stock price today i.e. is closed at $12.84,which is 82.43% down from its 52 week high and 15.36% up from its 52 week low.
What is Atrium Therapeutics, Inc.'s market capitalisation today?
Atrium Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Atrium Therapeutics, Inc. Stock (RNA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Atrium Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atrium Therapeutics, Inc. Shares that will get you 0.1168 shares as per Atrium Therapeutics, Inc. share price of $12.84 per share as on August 19, 2026 at 8:46 am IST.
What is the minimum amount required to buy Atrium Therapeutics, Inc. Stock (RNA) from India?
Indian investors can start investing in Atrium Therapeutics, Inc. (RNA) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in Atrium Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atrium Therapeutics, Inc. share’s latest price of $12.84 as on August 19, 2026 at 8:46 am IST, you will get 0.7788 shares of Atrium Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Atrium Therapeutics, Inc. has given to Indian investors in the last 5 years?
Atrium Therapeutics, Inc. stock has given -31.45% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?